サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1482004

欧州のビタミンK2：2030年までの市場予測 - 地域分析 - 製品、剤形、由来、用途別

Europe Vitamin K2 Market Forecast to 2030 - Regional Analysis - by Product, Dosage Forms, Source, and Application

出版日
ページ情報
英文 88 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
欧州のビタミンK2：2030年までの市場予測 - 地域分析 - 製品、剤形、由来、用途別
出版日: 2024年03月04日
発行: The Insight Partners
ページ情報: 英文 88 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州のビタミンK2市場は、2022年の5,327万米ドルから2030年には4億2,310万米ドルに成長すると予測されています。2022年から2030年までのCAGRは29.6%と推定されます。

成人および新生児における骨粗鬆症骨変形症例の増加が欧州のビタミンK2市場を活性化

骨粗鬆症は、成人や新生児に影響を及ぼす健康問題としてますます一般的になっており、骨が弱くもろくなることで特徴づけられる疾患です。国際骨粗鬆症財団（International Osteoporosis Foundation 2022）によると、世界的に骨粗鬆症は毎年890万人以上の骨折を引き起こし、その結果3秒ごとに骨粗鬆症性骨折が起きています。医療関係者は、骨粗鬆症に関連した骨の歪みの症例の急増を懸念しています。リサーチ・ゲートの最近の研究によれば、ビタミンK2の潜在的な利点は、骨の健康をサポートし、骨粗鬆症の結果を軽減する可能性があることです。

ビタミンK2は、あまり知られていないが、健康なカルシウム代謝と骨密度の維持に不可欠なビタミンKです。十分なミネラル化と強度を確保するために、カルシウムを血流から骨に移行させるタンパク質を刺激します。カルシウムの吸収をよくすることで、骨粗鬆症に関連した骨折や変形を防ぐのに役立つ栄養素です。成人の骨粗鬆症は、ホルモンの変化、加齢に伴う骨量の減少、または不十分な食物摂取から生じることが多いです。ビタミンK2の補給は、成人の骨密度を高め、骨折リスクを低下させるという有望な結果を示しています。さらに、女性は骨粗鬆症の罹患率が高いため、骨健康食品の主なターゲットです。骨粗鬆症に関連した困難の発生率の増加は、機能性食品にとって引き続き重要な焦点であり、カルシウムやビタミンDといったサプリメントは骨の健康を支える主要成分です。カルシウムは骨の主要なミネラル成分であり、ビタミンはカルシウムの吸収を助ける。さらに、ビタミンK2は、骨の劣化を引き起こす破骨細胞の活動を抑え、骨の完全性をさらに保護するのに役立つことが提唱されています。

新生児、特に早産児は骨粗鬆症になる可能性があります。骨が未熟で弱いため、骨折しやすいのです。ビタミンK2は骨の成長を改善し、これらの乳児の治療レジメンにおける骨異常の可能性を減らします。ビタミンK2の補給により骨格の発達が促進され、生後間もない時期に自然に起こる過程をサポートします。このように、骨粗鬆症に関連した骨異常の成人および新生児の発生件数が増加していることから、効率的な予防手段と治療アプローチが緊急に必要とされています。したがって、ビタミンK2サプリメントは、カルシウム代謝、骨ミネラル化、骨折予防を助ける潜在的な補助療法として機能します。これらすべての要因が市場の成長を促進しています。

欧州のビタミンK2市場概要

欧州のビタミンK2市場は、ドイツ、フランス、英国、イタリア、スペイン、その他欧州に区分されます。同市場の成長は、CVDの有病率の増加と成人および新生児における骨粗鬆症の骨変形症例の増加に起因しています。しかし、ビタミンK2の利点に関する認知度が低いことが市場成長の妨げとなっています。ドイツやイタリアといった国々がこの地域の市場成長に最も大きく貢献すると予想され、フランス、英国、スペインといった国々にもビタミンK2の成長機会があると思われます。欧州のビタミンK2市場は、美的外観に対する意識の高まりによる、非外科的スキンタイトニングや非外科的脂肪減少などの非侵襲的美容治療の急増により成長が期待されます。さらに、医療機器産業の発展や美容クリニックの増加も重要な成長機会となる可能性があります。

欧州のビタミンK2市場の収益と2030年までの予測（百万米国ドル）

欧州のビタミンK2市場セグメンテーション

欧州のビタミンK2市場は製品、剤形、由来、用途、国に区分されます。

製品別では、欧州のビタミンK2市場はMK-4、MK-7、配合剤に区分されます。2022年の欧州のビタミンK2市場では、MK-7セグメントが最大のシェアを占めています。

剤形別では、欧州のビタミンK2市場はカプセル＆錠剤、粉末、オイルに区分されます。粉末セグメントが2022年の欧州のビタミンK2市場で最大のシェアを占めました。

供給源に基づき、欧州のビタミンK2市場は天然と合成に区分されます。天然セグメントは2022年に欧州のビタミンK2市場でより大きなシェアを占めました。

用途別では、欧州のビタミンK2市場は医薬品、栄養補助食品、食品、その他に区分されます。医薬品セグメントが2022年の欧州のビタミンK2市場で最大のシェアを占めました。

国別では、欧州のビタミンK2市場は英国、ドイツ、フランス、イタリア、スペイン、その他欧州に区分されます。2022年の欧州のビタミンK2市場はドイツが独占

Anderson Global Group LLC、Balchem Corp、BASF SE、Glanbia Plc、International Flavors &Fragrances Inc、Koninklijke DSM NV、Lesaffre et Cie SA、Lonza Group AG、Novozymes ASは、欧州のビタミンK2市場で事業を展開する大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州のビタミンK2市場：主要産業力学

  • 主な市場促進要因
    • CVDの有病率の増加
    • 成人および新生児における骨粗鬆症の症例増加
  • 市場抑制要因
    • ビタミンK2の利点に関する認知度の低下
  • 市場機会
    • 流通チャネルの拡大
  • 今後の動向
    • 法規制と規格
  • 影響分析

第5章 ビタミンK2市場：欧州市場分析

  • 欧州のビタミンK2市場収益、2022-2030年

第6章 欧州のビタミンK2市場 - 収益と2030年までの予測：製品別

  • 市場収益シェア、2022年および2030年
  • MK-4
  • MK-7
  • 配合剤

第7章 欧州のビタミンK2市場 - 収益と2030年までの予測：剤形別

  • 市場収益シェア、2022年および2030年
  • カプセルと錠剤
  • 粉末
  • オイル

第8章 欧州のビタミンK2市場 - 収益と2030年までの予測：由来別

  • 市場収益シェア、2022年および2030年
  • 天然
  • 合成

第9章 欧州のビタミンK2市場 - 収益と2030年までの予測：用途別

  • 市場収益シェア、2022年および2030年
  • 医薬品
  • 栄養補助食品と食品
  • その他

第10章 欧州のビタミンK2市場：国別分析

    • 欧州のビタミンK2市場：国別
      • ドイツ
      • 英国
      • フランス
      • イタリア
      • スペイン
      • その他欧州

第11章 ビタミンK2市場業界情勢

  • ビタミンK2市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • Lonza Group AG
  • International Flavors & Fragrances Inc
  • Balchem Corp
  • BASF SE
  • Lesaffre et Cie SA
  • Koninklijke DSM NV
  • Novozymes AS
  • Glanbia Plc
  • Anderson Global Group LLC

第13章 付録

図表

List Of Tables

  • Table 1. Europe Vitamin K2 Market Segmentation
  • Table 2. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 3. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
  • Table 4. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 5. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 6. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 7. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
  • Table 8. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 9. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 10. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 11. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
  • Table 12. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 13. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 14. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 15. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
  • Table 16. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 17. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 18. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 19. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
  • Table 20. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 21. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 22. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 23. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
  • Table 24. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 25. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 26. Recent Organic Growth Strategies in Vitamin K2 Market
  • Table 27. Recent Inorganic Growth Strategies in the Vitamin K2 Market
  • Table 28. Glossary of Terms, Europe Vitamin K2 Market

List Of Figures

  • Figure 1. Europe Vitamin K2 Market Segmentation, By Country
  • Figure 2. Europe Vitamin K2 Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Vitamin K2 Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Europe Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 6. MK-4: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. MK-7: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Combination Drugs: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Europe Vitamin K2 Market Revenue Share, by Dosage Form 2022 & 2030 (%)
  • Figure 10. Capsules and Tablets: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Powder: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Oil: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Europe Vitamin K2 Market Revenue Share, by Source 2022 & 2030 (%)
  • Figure 14. Natural: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Synthetic: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Europe Vitamin K2 Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 17. Pharmaceuticals: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Nutraceuticals and Food: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Europe Vitamin K2 Market, By Country, 2022 ($Mn)
  • Figure 21. Europe Vitamin K2 Market, By Key Countries, 2022 And 2030 (%)
  • Figure 22. AS is the most common valvular heart disease, with a dismal prognosis when untreated. Recommended therapy is SAVR or TAVR.
  • Figure 23. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 24. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 25. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 26. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 27. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 28. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 29. Growth Strategies in Vitamin K2 Market
目次
Product Code: BMIRE00029721

The Europe vitamin K2 market is expected to grow from US$ 53.27 million in 2022 to US$ 423.10 million by 2030. It is estimated to grow at a CAGR of 29.6% from 2022 to 2030.

Growing Cases of Osteoporosis Bone Deformation in Adults and Newborns Fuels Europe Vitamin K2 Market

Osteoporosis is an increasingly common health issue affecting adults and babies, a disorder marked by weakening and fragile bones. According to International Osteoporosis Foundation 2022, globally osteoporosis causes more than 8.9 million fractures every year resulting in osteoporotic fracture in every 3 seconds. Medical professionals are concerned about the surge in osteoporosis-related bone distortion cases. As per recent studies from Research Gate, the potential advantages of vitamin K2 include supporting bone health and possibly reducing the consequences of osteoporosis.

Vitamin K2 is a lesser-known vitamin K essential for maintaining healthy calcium metabolism and bone density. It stimulates proteins that transfer calcium from the bloodstream into the bones to ensure adequate mineralization and strength. The nutrient aid in avoiding osteoporosis-related bone fractures and deformities by improving calcium absorption. Adult osteoporosis cases frequently result from hormonal changes, age-related bone loss, or inadequate food intake. Vitamin K2 supplementation has demonstrated promising outcomes in enhancing bone mineral density and lowering fracture risk among adults. In addition, women are the main target for bone health products due to their higher incidence of osteoporosis. The increasing incidence of osteoporosis-related difficulties continues to be a key focus for functional foods and supplements such as calcium and vitamin D are the primary components supporting bone health. Calcium is the main mineral component of bones, while vitamin helps with calcium absorption. changes However, as consumers are becoming more aware of the benefits of vitamin K2, its availability in foods and supplements is rising. In addition, it has been proposed that vitamin K2 aids in reducing the activity of osteoclast cells, which are responsible for bone deterioration, further protecting bone integrity.

Newborns can develop osteoporosis, especially preterm babies. They are more prone to fractures since their bones are immature and weak. Vitamin K2 improves bone growth and lessens the likelihood of bone abnormalities in the therapy regimens for these infants. Their skeletal development is accelerated by vitamin K2 supplementation, which supports the naturally occurring processes during the early stages of life. Thus, the growing number of adult and neonatal incidences of osteoporosis-related bone abnormalities creates the urgent need for efficient preventative measures and treatment approaches. Hence, vitamin K2 supplementation acts as a potential supplementary therapy that helps with calcium metabolism, bone mineralization, and the prevention of fractures. All these factors are driving the market growth.

Europe Vitamin K2 Market Overview

The Europe vitamin K2 market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The growth of the market is attributed to the increasing prevalence of CVD and growing cases of osteoporosis bone deformation in adults and newborns. However, the limited awareness regarding benefits of vitamin K2 hinders the market growth. Countries such as Germany and Italy are expected to be the most significant contributors to market growth in the region and countries such as France, the UK, and Spain are likely to have growth opportunities for vitamin K2. The European vitamin K2 market is expected to grow owing to the surge in non-invasive aesthetic treatments such as non-surgical skin tightening and non-surgical fat reductions due to increased awareness of aesthetic appearance. Furthermore, the medical devices industry developments and the rising numbers of aesthetic clinics may offer vital growth opportunities.

Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)

Europe Vitamin K2 Market Segmentation

The Europe vitamin K2 market is segmented into product, dosage forms, source, application, and country.

Based on product, the Europe vitamin K2 market is segmented into MK-4, MK-7, and combination drugs. The MK-7 segment held the largest share of the Europe vitamin K2 market in 2022.

Based on dosage forms, the Europe vitamin K2 market is segmented into capsules & tablets, powder, and oils. The powder segment held the largest share of the Europe vitamin K2 market in 2022.

Based on source, the Europe vitamin K2 market is segmented into natural and synthetic. The natural segment held a larger share of the Europe vitamin K2 market in 2022.

Based on application, the Europe vitamin K2 market is segmented into pharmaceuticals, nutraceuticals and food, and others. The pharmaceuticals segment held the largest share of the Europe vitamin K2 market in 2022.

Based on country, the Europe vitamin K2 market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe vitamin K2 market in 2022.

Anderson Global Group LLC, Balchem Corp, BASF SE, Glanbia Plc, International Flavors & Fragrances Inc, Koninklijke DSM NV, Lesaffre et Cie SA, Lonza Group AG, and Novozymes AS are some of the leading companies operating in the Europe vitamin K2 market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Vitamin K2 Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Increasing Prevalence of CVD
    • 4.1.2 Growing Cases of Osteoporosis Bone Deformation in Adults and Newborns
  • 4.2 Market Restraints
    • 4.2.1 Limited Awareness Regarding Benefits of Vitamin K2
  • 4.3 Market Opportunities
    • 4.3.1 Expansion of Distribution Channel
  • 4.4 Future Trends
    • 4.4.1 Regulatory Consideration and Standards
  • 4.5 Impact Analysis:

5. Vitamin K2 Market - Europe Market Analysis

  • 5.1 Europe Vitamin K2 Market Revenue (US$ Mn), 2022 - 2030

6. Europe Vitamin K2 Market - Revenue and Forecast to 2030 - by Product.

  • 6.1 Overview
  • 6.2 Europe Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
  • 6.3 MK-4
    • 6.3.1 Overview
    • 6.3.2 MK-4: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 MK-7
    • 6.4.1 Overview
    • 6.4.2 MK-7: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Combination Drugs
    • 6.5.1 Overview
    • 6.5.2 Combination Drugs: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Vitamin K2 Market - Revenue and Forecast to 2030 - by Dosage Form.

  • 7.1 Overview
  • 7.2 Europe Vitamin K2 Market Revenue Share, by Dosage Form, 2022 & 2030 (%)
  • 7.3 Capsules and Tablets
    • 7.3.1 Overview
    • 7.3.2 Capsules and Tablets: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Powder
    • 7.4.1 Overview
    • 7.4.2 Powder: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Oil
    • 7.5.1 Overview
    • 7.5.2 Oil: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Vitamin K2 Market - Revenue and Forecast to 2030 - by Source.

  • 8.1 Overview
  • 8.2 Europe Vitamin K2 Market Revenue Share, by Source, 2022 & 2030 (%)
  • 8.3 Natural
    • 8.3.1 Overview
    • 8.3.2 Natural: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Synthetic
    • 8.4.1 Overview
    • 8.4.2 Synthetic: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Vitamin K2 Market - Revenue and Forecast to 2030 - by Application.

  • 9.1 Overview
  • 9.2 Europe Vitamin K2 Market Revenue Share, by Application, 2022 & 2030 (%)
  • 9.3 Pharmaceuticals
    • 9.3.1 Overview
    • 9.3.2 Pharmaceuticals: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Nutraceuticals and Food
    • 9.4.1 Overview
    • 9.4.2 Nutraceuticals and Food: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Vitamin K2 Market - Country Analysis

    • 10.1.1 Europe Vitamin K2 Market by Country
      • 10.1.1.1 Germany
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 Germany: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.1.3 Germany: Europe Vitamin K2 Market, by Product
        • 10.1.1.1.4 Germany: Europe Vitamin K2 Market, by Dosage Form
        • 10.1.1.1.5 Germany: Europe Vitamin K2 Market, by Source
        • 10.1.1.1.6 Germany: Europe Vitamin K2 Market, by Application
      • 10.1.1.2 UK
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 UK: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.3 UK: Europe Vitamin K2 Market, by Product
        • 10.1.1.2.4 UK: Europe Vitamin K2 Market, by Dosage Form
        • 10.1.1.2.5 UK: Europe Vitamin K2 Market, by Source
        • 10.1.1.2.6 UK: Europe Vitamin K2 Market, by Application
      • 10.1.1.3 France
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 France: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.3 France: Europe Vitamin K2 Market, by Product
        • 10.1.1.3.4 France: Europe Vitamin K2 Market, by Dosage Form
        • 10.1.1.3.5 France: Europe Vitamin K2 Market, by Source
        • 10.1.1.3.6 France: Europe Vitamin K2 Market, by Application
      • 10.1.1.4 Italy
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Italy: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.3 Italy: Europe Vitamin K2 Market, by Product
        • 10.1.1.4.4 Italy: Europe Vitamin K2 Market, by Dosage Form
        • 10.1.1.4.5 Italy: Europe Vitamin K2 Market, by Source
        • 10.1.1.4.6 Italy: Europe Vitamin K2 Market, by Application
      • 10.1.1.5 Spain
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Spain: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.5.3 Spain: Europe Vitamin K2 Market, by Product
        • 10.1.1.5.4 Spain: Europe Vitamin K2 Market, by Dosage Form
        • 10.1.1.5.5 Spain: Europe Vitamin K2 Market, by Source
        • 10.1.1.5.6 Spain: Europe Vitamin K2 Market, by Application
      • 10.1.1.6 Rest of Europe
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Europe: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.6.3 Rest of Europe: Europe Vitamin K2 Market, by Product
        • 10.1.1.6.4 Rest of Europe: Europe Vitamin K2 Market, by Dosage Form
        • 10.1.1.6.5 Rest of Europe: Europe Vitamin K2 Market, by Source
        • 10.1.1.6.6 Rest of Europe: Europe Vitamin K2 Market, by Application

11. Vitamin K2 Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Vitamin K2 Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Lonza Group AG
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 International Flavors & Fragrances Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Balchem Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 BASF SE
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Lesaffre et Cie SA
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Koninklijke DSM NV
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Novozymes AS
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Glanbia Plc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Anderson Global Group LLC
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms